Royalty Pharma (RPRX) operating margin

Operating margin · fiscal 2025
65.6%

Royalty Pharma (RPRX) had an operating margin of 65.6% in fiscal 2025 (the year ended December 31, 2025). That is 8.5 percentage points higher than the 57.1% of fiscal 2024. Figures as of 17 Nov 2026, 20:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
65.6%
Change on fiscal 2024
+8.5 pts
Highest on record
144.6%fiscal 2019
Lowest on record
41.3%fiscal 2022
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Royalty Pharma operating margin, in more detail

Across the 8 fiscal years on record (2018–2025), the highest was 144.6% in fiscal 2019 and the lowest 41.3% in fiscal 2022. The fiscal 2025 figure is higher than in 57% of the 7 earlier fiscal years on record, whose median is 63.4%.

Net margin was 32.4% in fiscal 2025.

History · 8 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Net margin

Royalty Pharma operating margin, year by year

Royalty Pharma (RPRX) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedNet margin
202565.6% 8.5 pts up32.4%
202457.1% 6.3 pts down37.9%
202363.4% 22.1 pts up48.2%
202241.3% 21.2 pts down1.9%
202162.5% 12.7 pts down27.1%
202075.2% 69.4 pts down45.9%
2019144.6% 68.6 pts up129.4%
201876.0%—76.8%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Royalty Pharma and comparable companies
CompanyOperating marginFiscal year
IQVIA Holdings IQV14.0%2025
Revolution Medicines RVMD-4207.1%2023
Royalty Pharma RPRX65.6%2025
Biogen BIIB25.0%2025
GE HealthCare Technologies GEHC13.4%2025
Alcon ALC13.1%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RPRX

Royalty Pharma, figure by figure

Royalty Pharma (RPRX) overview: price, valuation and scorecardAll health care companies by market value

Royalty Pharma operating margin: questions and answers

What is Royalty Pharma's operating margin?

Royalty Pharma (RPRX) had an operating margin of 65.6% in fiscal 2025 (the year ended December 31, 2025). That is 8.5 percentage points higher than the 57.1% of fiscal 2024.

Is Royalty Pharma's operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 57% of the 7 earlier fiscal years on record, whose median is 63.4%.

What are the highest and lowest operating margin figures on record for Royalty Pharma?

Across the 8 fiscal years on record (2018–2025), the highest was 144.6% in fiscal 2019 and the lowest 41.3% in fiscal 2022.

What are Royalty Pharma's gross and net margins?

Net margin was 32.4% in fiscal 2025.

How is Royalty Pharma's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Royalty Pharma (RPRX) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/RPRX/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.